Pharmaceutical Industry Articles & Reports - Page 19

Explore how AI target discovery and graph-based machine learning platforms like bfLEAP address R&D challenges in central nervous system drug development.

Examine clinical evidence generation for AI diagnostic SaMD. This report covers real-world performance studies, FDA guidelines, and post-market surveillance.

Review the $12B wave of Q1 2026 oncology AI deals and pharma M&A. This analysis explains how patent cliffs, CAR-T, and AI drug discovery drive acquisitions.

Guide to designing an AI training program for pharmaceutical teams. Review role-based curriculum development, learning tools, and ROI measurement frameworks.

Analyze how Roche utilizes its NVIDIA AI factory, featuring 3,500 GPUs and Omniverse digital twins, to scale GLP-1 drug manufacturing and optimize pharma R&D.

Examine the 2026 AI digital health landscape. Learn how Big Tech, pharmaceutical companies, and startups compete and collaborate in AI-powered healthcare.

This analysis examines AI in the pharmaceutical supply chain, detailing machine learning applications for demand forecasting, procurement, and logistics.

Review the ICH E6(R3) Good Clinical Practice (GCP) updates, exploring Risk-Based Quality Management (RBQM), new Annex structures, and implementation steps.

Understand ICH Q7 GMP guidelines for active pharmaceutical ingredients (APIs). Review compliance requirements, quality management systems, and FDA regulations.

Analyze the $2.75B partnership between Eli Lilly and Insilico Medicine. Understand how generative AI impacts pharma R&D strategy and drug commercialization.

Examine the role of AI in clinical trial protocol design. This report analyzes how BMS, Faro Health, and Evinova use digital protocols in drug development.

Analyze Earendil Labs' $787M funding and its implications for AI biologics. This educational report examines pharma AI investments and protein drug discovery.

Analyze Anthropic's $400M acquisition of Coefficient Bio. This report details the integration of large language models and AI in pharmaceutical drug discovery.

Learn how the Dotmatics platform integrates AI into life sciences R&D. This report examines Luma architecture, ELN systems, FAIR data, and lab informatics.

Review AI policies and data classification frameworks used in clinical-stage biotech. Learn how to govern trial data and navigate global AI compliance laws.

Understand ChatGPT Enterprise connectors and Office 365, SharePoint, and Azure integrations. This guide explains RAG architecture, security, and governance.

Analyze token usage patterns and optimization techniques for ChatGPT and Claude. Understand LLM context windows, API costs, and prompt engineering strategies.

Analyze the role of AI in pharma and biotech. Learn how machine learning is applied to drug discovery and clinical trials through industry case studies.

Learn how Egnyte AI and the Model Context Protocol (MCP) integrate secure generative AI and RAG into enterprise content management and data governance.

A factual comparison of ChatGPT Enterprise vs Claude Enterprise. Analyze context windows, compliance controls, model capabilities, and enterprise pricing.

Read an in-depth 2026 comparison of leading AI coding assistants: Claude Code, Codex CLI, and Gemini CLI. Review their features, models, and market adoption.

Examine Amgen's phased enterprise AI rollout to 20,000 employees. Learn about the Microsoft Copilot pilot, security guardrails, and AI adoption metrics.

An educational guide detailing prompt strategies for ChatGPT and Claude in biotechnology. Covers prompt engineering techniques, model comparisons, and examples.

Review a comprehensive directory of Claude Cowork training resources. Access official documentation, community tutorials, video courses, and expert workshops.